SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Dec 04, 2023	View HTML 0001959173-23-005166.pdf 0001959173-23-005166.rtf 0001959173-23-005166.xls
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Dec 04, 2023	View HTML 0001950047-23-005612.pdf 0001950047-23-005612.rtf
144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Dec 04, 2023	View HTML 0001950047-23-005610.pdf 0001950047-23-005610.rtf 0001950047-23-005610.xls
144/A	Amendment to a previously filed 144	Dec 04, 2023	View HTML 0001959173-23-005181.pdf 0001959173-23-005181.rtf 0001959173-23-005181.xls
424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Dec 04, 2023	View HTML 0001193125-23-288522.pdf 0001193125-23-288522.rtf
8-K	Report of unscheduled material events or corporate event	Nov 09, 2023	View HTML 0000950170-23-061549.pdf 0000950170-23-061549.rtf 0000950170-23-061549.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
10-Q	Quarterly report which provides a continuing view of a company's financial position	Nov 03, 2023	View HTML 0000950170-23-058775.pdf 0000950170-23-058775.rtf 0000950170-23-058775.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
8-K	Report of unscheduled material events or corporate event	Nov 01, 2023	View HTML 0000950170-23-057119.pdf 0000950170-23-057119.rtf 0000950170-23-057119.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
EFFECT	EFFECT	Oct 30, 2023	View HTML 9999999995-23-003140.pdf 9999999995-23-003140.rtf 9999999995-23-003140.xls
CORRESP	CORRESP	Oct 26, 2023	View HTML 0001193125-23-263644.pdf 0001193125-23-263644.rtf 0001193125-23-263644.xls

Data provided by Kaleidoscope.